Why the study?
Conventional poliovirus neutralization tests are laborious, time-consuming, and unsuitable for large-scale analysis in clinical studies, surveillance, and seroprevalence efforts.
Does the multiplex PCR-based neutralization (MPBN) assay accurately and rapidly measure anti-poliovirus neutralizing antibody titers compared to the conventional neutralization test?
Does the multiplex PCR-based neutralization (MPBN) assay accurately and rapidly measure anti-poliovirus neutralizing antibody titers compared to the conventional neutralization test?
The MPBN assay provides a rapid, reproducible, and sensitive method for titrating anti-poliovirus antibodies against three serotypes simultaneously, facilitating large-scale vaccine and epidemiological studies.
Answers are grounded in this paper and cite their sources.
May enable scalable polio serosurveillance; leaves open validation against conventional neutralization testing.
Determination of poliovirus-neutralizing antibodies is an important part of clinical studies of poliovirus vaccines, epidemiological surveillance and seroprevalence studies that are crucial for global polio eradication campaigns. The conventional neutralization test is based on inhibition of cytopathic effect caused by poliovirus by serial dilutions of test serum. It is laborious, time-consuming and not suitable for large scale analysis. To overcome these limitations, a multiplex PCR-based neutralization (MPBN) assay was developed to measure the neutralizing antibody titers of anti-poliovirus sera against three serotypes of the virus in the same reaction and in shorter time. All three anti-poliovirus sera types were analyzed in a single assay. The MPBN assay was reproducible, robust and sensitive. Its lower limits of titration for the three anti-poliovirus sera types were within range of 0.76-1.64 per mL. Different anti-poliovirus sera were tested with conventional and MPBN assays; the results obtained by both methods correlated well and generated similar results. The MPBN is the first neutralization assay that specifically titrates anti-poliovirus antibodies against the three serotypes of the virus in the same reaction; it can be completed in two to three days instead of ten days for the conventional assay and can be automated for high-throughput implementation.
No takes yet. Share an insight, caveat, or question.
Manukyan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: